Loss of endothelial CFTR drives barrier failure and edema formation in lung infection and can be targeted by CFTR potentiation.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
07 12 2022
Historique:
entrez: 8 12 2022
pubmed: 9 12 2022
medline: 15 12 2022
Statut: ppublish

Résumé

Pneumonia is the most common cause of the acute respiratory distress syndrome (ARDS). Here, we identified loss of endothelial cystic fibrosis transmembrane conductance regulator (CFTR) as an important pathomechanism leading to lung barrier failure in pneumonia-induced ARDS. CFTR was down-regulated after

Identifiants

pubmed: 36475904
doi: 10.1126/scitranslmed.abg8577
doi:

Substances chimiques

Chlorides 0
Calcium SY7Q814VUP
CFTR protein, human 0
Cystic Fibrosis Transmembrane Conductance Regulator 126880-72-6
Trpv4 protein, mouse 0
TRPV Cation Channels 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabg8577

Auteurs

Lasti Erfinanda (L)

Institute of Physiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Lin Zou (L)

Institute of Physiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
German Heart Center, 13353 Berlin, Germany.
Department of Endocrinology, Shanghai Pudong New Area Gongli Hospital, 200135 Shanghai, China.

Birgitt Gutbier (B)

Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.

Laura Kneller (L)

Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.

Sarah Weidenfeld (S)

Institute of Physiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Laura Michalick (L)

Institute of Physiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Disi Lei (D)

Institute of Physiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
German Heart Center, 13353 Berlin, Germany.

Katrin Reppe (K)

Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.

Luiz Gustavo Teixeira Alves (LG)

Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.

Bill Schneider (B)

Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.

Qi Zhang (Q)

Institute of Physiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Caihong Li (C)

Institute of Physiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Diana Fatykhova (D)

Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.

Paul Schneider (P)

Department for General and Thoracic Surgery, DRK Clinics, 13359 Berlin, Germany.

Wolfgang Liedtke (W)

Departments of Neurology, Neurobiology, and Clinics for Pain and Palliative Care, Duke University Medical Center, Durham, NC 27710, USA.

Eisei Sohara (E)

Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.

Timothy J Mitchell (TJ)

Institute of Microbiology and Infection, University of Birmingham, Birmingham B15-2TT, UK.

Achim D Gruber (AD)

Institute of Veterinary Pathology, Freie Universität Berlin, 14163 Berlin, Germany.

Andreas Hocke (A)

Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
German Center for Lung Research (DZL), associated partner site, 10117 Berlin, Germany.

Stefan Hippenstiel (S)

Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
German Center for Lung Research (DZL), associated partner site, 10117 Berlin, Germany.

Norbert Suttorp (N)

Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
German Center for Lung Research (DZL), associated partner site, 10117 Berlin, Germany.

Andrea Olschewski (A)

Experimental Anaesthesiology, Department of Anaesthesiology and Intensive Care Medicine, Medical University of Graz, 8010 Graz, Austria.

Marcus A Mall (MA)

German Center for Lung Research (DZL), associated partner site, 10117 Berlin, Germany.
Department of Pediatric Pulmonology, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, 13353 Berlin, Germany.

Martin Witzenrath (M)

Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
German Center for Lung Research (DZL), associated partner site, 10117 Berlin, Germany.

Wolfgang M Kuebler (WM)

Institute of Physiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
German Center for Lung Research (DZL), associated partner site, 10117 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH